403 related articles for article (PubMed ID: 33845756)
1. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
4. NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.
Nagata T; Ohara T; Hata J; Sakata S; Furuta Y; Yoshida D; Honda T; Hirakawa Y; Ide T; Kanba S; Kitazono T; Tsutsui H; Ninomiya T
J Am Heart Assoc; 2019 Sep; 8(17):e011652. PubMed ID: 31446828
[TBL] [Abstract][Full Text] [Related]
5. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
[TBL] [Abstract][Full Text] [Related]
6. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
Hussain A; Sun W; Deswal A; de Lemos JA; McEvoy JW; Hoogeveen RC; Matsushita K; Aguilar D; Bozkurt B; Virani SS; Shah AM; Selvin E; Ndumule C; Ballantyne CM; Nambi V
J Am Coll Cardiol; 2021 Feb; 77(5):559-571. PubMed ID: 33538254
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
8. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
9. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
Ezekowitz JA; O'Connor CM; Troughton RW; Alemayehu WG; Westerhout CM; Voors AA; Butler J; Lam CSP; Ponikowski P; Emdin M; Patel MJ; Pieske B; Roessig L; Hernandez AF; Armstrong PW
JACC Heart Fail; 2020 Nov; 8(11):931-939. PubMed ID: 33039447
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events - The Japan Morning Surge-Home Blood Pressure Study.
Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
[TBL] [Abstract][Full Text] [Related]
11. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
12. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
13. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
[TBL] [Abstract][Full Text] [Related]
14. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
17. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.
Patton KK; Sotoodehnia N; DeFilippi C; Siscovick DS; Gottdiener JS; Kronmal RA
Heart Rhythm; 2011 Feb; 8(2):228-33. PubMed ID: 21044699
[TBL] [Abstract][Full Text] [Related]
19. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
[TBL] [Abstract][Full Text] [Related]
20. Serum N-terminal pro-B-type natriuretic peptide as a predictor for future development of atrial fibrillation in a general population: the Hisayama Study.
Nagata T; Hata J; Sakata S; Oishi E; Honda T; Furuta Y; Ohara T; Yoshida D; Hirakawa Y; Shibata M; Ide T; Kitazono T; Tsutsui H; Ninomiya T
Int J Cardiol; 2020 Dec; 320():90-96. PubMed ID: 32592745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
